Patent · US Active

N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereof

US7547708B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignee

Solvay Pharmaceuticals, GmbH · US

Inventors

Jochen Antel · Annaberg-Buchholz, DE
Harald Waldeck · Hannover, DE
Uwe Schoen · Burgdorf, DE
Peter-Colin Gregory · Hannover, DE
Michael Wurl · Garbsen, DE
Michael Firnges · Barsinghausen, DE
Dania Birte REICHE · Bingen, DE
Uwe Reinecker · Ronnenberg, DE
Holger Sann · Hannover, DE

Key dates

Filing date	Nov 14, 2006
Grant date	Jun 16, 2009
Priority date	—
Expiry date	Nov 25, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

N-sulfamoyl-N′-benzopyranpiperidine compounds of formula I and their physiologically acceptable acid addition salts, pharmaceutical compositions comprising them, processes for their preparation, and their use for the treatment and/or inhibition of glaucoma, epilepsy, bipolar disorders, migraine, neuropathic pain, obesity, type II diabetes, metabolic syndrome, alcohol dependence, and/or cancer, and related concomitant and/or secondary diseases or conditions

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.